Skip to main content
NCBI home page
Biophysical Journal logoLink to Biophysical Journal
. 2000 Oct;79(4):2075–2083. doi: 10.1016/S0006-3495(00)76455-1

Polar angle as a determinant of amphipathic alpha-helix-lipid interactions: a model peptide study.

N Uematsu 1, K Matsuzaki 1
PMCID: PMC1301097  PMID: 11023911

Abstract

Various physicochemical properties play important roles in the membrane activities of amphipathic antimicrobial peptides. To examine the effects of the polar angle, two model peptides, thetap100 and thetap180, with polar angles of 100 degrees and 180 degrees, respectively, were designed, and their interactions with membranes were investigated in detail. These peptides have almost identical physicochemical properties except for polar angle. Like naturally occurring peptides, these peptides selectively bind to acidic membranes, assuming amphipathic alpha-helices, and formed peptide-lipid supramolecular complex pores accompanied by lipid flip-flop and peptide translocation. Despite its somewhat lower membrane affinity, thetap100 exhibited higher membrane permeabilization activity, a greater flip-flop rate, as well as more antimicrobial activity due to a higher pore formation rate compared with thetap180. Consistent with these results, the peptide translocation rate of thetap100 was higher. Furthermore, the number of peptides constituting thetap100 pores was less than that of thetap180, and thetap100 pores involved more lipid molecules, as reflected by its cation selectivity. The polar angle was found to be an important parameter determining peptide-lipid interactions.

Full Text

The Full Text of this article is available as a PDF (114.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARTLETT G. R. Phosphorus assay in column chromatography. J Biol Chem. 1959 Mar;234(3):466–468. [PubMed] [Google Scholar]
  2. Bechinger B. The structure, dynamics and orientation of antimicrobial peptides in membranes by multidimensional solid-state NMR spectroscopy. Biochim Biophys Acta. 1999 Dec 15;1462(1-2):157–183. doi: 10.1016/s0005-2736(99)00205-9. [DOI] [PubMed] [Google Scholar]
  3. Blondelle S. E., Houghten R. A. Design of model amphipathic peptides having potent antimicrobial activities. Biochemistry. 1992 Dec 22;31(50):12688–12694. doi: 10.1021/bi00165a020. [DOI] [PubMed] [Google Scholar]
  4. Dathe M., Schümann M., Wieprecht T., Winkler A., Beyermann M., Krause E., Matsuzaki K., Murase O., Bienert M. Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes. Biochemistry. 1996 Sep 24;35(38):12612–12622. doi: 10.1021/bi960835f. [DOI] [PubMed] [Google Scholar]
  5. Dathe M., Wieprecht T., Nikolenko H., Handel L., Maloy W. L., MacDonald D. L., Beyermann M., Bienert M. Hydrophobicity, hydrophobic moment and angle subtended by charged residues modulate antibacterial and haemolytic activity of amphipathic helical peptides. FEBS Lett. 1997 Feb 17;403(2):208–212. doi: 10.1016/s0014-5793(97)00055-0. [DOI] [PubMed] [Google Scholar]
  6. Deisenhofer J., Michel H. Nobel lecture. The photosynthetic reaction centre from the purple bacterium Rhodopseudomonas viridis. EMBO J. 1989 Aug;8(8):2149–2170. doi: 10.1002/j.1460-2075.1989.tb08338.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Epand R. M., Shai Y., Segrest J. P., Anantharamaiah G. M. Mechanisms for the modulation of membrane bilayer properties by amphipathic helical peptides. Biopolymers. 1995;37(5):319–338. doi: 10.1002/bip.360370504. [DOI] [PubMed] [Google Scholar]
  8. Hancock R. E., Falla T., Brown M. Cationic bactericidal peptides. Adv Microb Physiol. 1995;37:135–175. doi: 10.1016/s0065-2911(08)60145-9. [DOI] [PubMed] [Google Scholar]
  9. Hancock R. E. Host defence (cationic) peptides: what is their future clinical potential? Drugs. 1999 Apr;57(4):469–473. doi: 10.2165/00003495-199957040-00002. [DOI] [PubMed] [Google Scholar]
  10. Hoffmann W., Richter K., Kreil G. A novel peptide designated PYLa and its precursor as predicted from cloned mRNA of Xenopus laevis skin. EMBO J. 1983;2(5):711–714. doi: 10.1002/j.1460-2075.1983.tb01489.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Javadpour M. M., Juban M. M., Lo W. C., Bishop S. M., Alberty J. B., Cowell S. M., Becker C. L., McLaughlin M. L. De novo antimicrobial peptides with low mammalian cell toxicity. J Med Chem. 1996 Aug 2;39(16):3107–3113. doi: 10.1021/jm9509410. [DOI] [PubMed] [Google Scholar]
  12. Ladokhin A. S., Wimley W. C., White S. H. Leakage of membrane vesicle contents: determination of mechanism using fluorescence requenching. Biophys J. 1995 Nov;69(5):1964–1971. doi: 10.1016/S0006-3495(95)80066-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Landolt-Marticorena C., Williams K. A., Deber C. M., Reithmeier R. A. Non-random distribution of amino acids in the transmembrane segments of human type I single span membrane proteins. J Mol Biol. 1993 Feb 5;229(3):602–608. doi: 10.1006/jmbi.1993.1066. [DOI] [PubMed] [Google Scholar]
  14. Maloy W. L., Kari U. P. Structure-activity studies on magainins and other host defense peptides. Biopolymers. 1995;37(2):105–122. doi: 10.1002/bip.360370206. [DOI] [PubMed] [Google Scholar]
  15. Matsuzaki K., Harada M., Funakoshi S., Fujii N., Miyajima K. Physicochemical determinants for the interactions of magainins 1 and 2 with acidic lipid bilayers. Biochim Biophys Acta. 1991 Mar 18;1063(1):162–170. doi: 10.1016/0005-2736(91)90366-g. [DOI] [PubMed] [Google Scholar]
  16. Matsuzaki K. Magainins as paradigm for the mode of action of pore forming polypeptides. Biochim Biophys Acta. 1998 Nov 10;1376(3):391–400. doi: 10.1016/s0304-4157(98)00014-8. [DOI] [PubMed] [Google Scholar]
  17. Matsuzaki K., Mitani Y., Akada K. Y., Murase O., Yoneyama S., Zasloff M., Miyajima K. Mechanism of synergism between antimicrobial peptides magainin 2 and PGLa. Biochemistry. 1998 Oct 27;37(43):15144–15153. doi: 10.1021/bi9811617. [DOI] [PubMed] [Google Scholar]
  18. Matsuzaki K., Murase O., Fujii N., Miyajima K. An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. Biochemistry. 1996 Sep 3;35(35):11361–11368. doi: 10.1021/bi960016v. [DOI] [PubMed] [Google Scholar]
  19. Matsuzaki K., Murase O., Fujii N., Miyajima K. Translocation of a channel-forming antimicrobial peptide, magainin 2, across lipid bilayers by forming a pore. Biochemistry. 1995 May 16;34(19):6521–6526. doi: 10.1021/bi00019a033. [DOI] [PubMed] [Google Scholar]
  20. Matsuzaki K., Murase O., Miyajima K. Kinetics of pore formation by an antimicrobial peptide, magainin 2, in phospholipid bilayers. Biochemistry. 1995 Oct 3;34(39):12553–12559. doi: 10.1021/bi00039a009. [DOI] [PubMed] [Google Scholar]
  21. Matsuzaki K., Murase O., Tokuda H., Funakoshi S., Fujii N., Miyajima K. Orientational and aggregational states of magainin 2 in phospholipid bilayers. Biochemistry. 1994 Mar 22;33(11):3342–3349. doi: 10.1021/bi00177a027. [DOI] [PubMed] [Google Scholar]
  22. Matsuzaki K., Nakai S., Handa T., Takaishi Y., Fujita T., Miyajima K. Hypelcin A, an alpha-aminoisobutyric acid containing antibiotic peptide, induced permeability change of phosphatidylcholine bilayers. Biochemistry. 1989 Nov 28;28(24):9392–9398. doi: 10.1021/bi00450a021. [DOI] [PubMed] [Google Scholar]
  23. Matsuzaki K., Nakamura A., Murase O., Sugishita K., Fujii N., Miyajima K. Modulation of magainin 2-lipid bilayer interactions by peptide charge. Biochemistry. 1997 Feb 25;36(8):2104–2111. doi: 10.1021/bi961870p. [DOI] [PubMed] [Google Scholar]
  24. Matsuzaki K., Sugishita K., Fujii N., Miyajima K. Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 2. Biochemistry. 1995 Mar 14;34(10):3423–3429. doi: 10.1021/bi00010a034. [DOI] [PubMed] [Google Scholar]
  25. Matsuzaki K., Sugishita K., Harada M., Fujii N., Miyajima K. Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteria. Biochim Biophys Acta. 1997 Jul 5;1327(1):119–130. doi: 10.1016/s0005-2736(97)00051-5. [DOI] [PubMed] [Google Scholar]
  26. Matsuzaki K., Sugishita K., Ishibe N., Ueha M., Nakata S., Miyajima K., Epand R. M. Relationship of membrane curvature to the formation of pores by magainin 2. Biochemistry. 1998 Aug 25;37(34):11856–11863. doi: 10.1021/bi980539y. [DOI] [PubMed] [Google Scholar]
  27. Matsuzaki K. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim Biophys Acta. 1999 Dec 15;1462(1-2):1–10. doi: 10.1016/s0005-2736(99)00197-2. [DOI] [PubMed] [Google Scholar]
  28. Matsuzaki K., Yoneyama S., Miyajima K. Pore formation and translocation of melittin. Biophys J. 1997 Aug;73(2):831–838. doi: 10.1016/S0006-3495(97)78115-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Matsuzaki K., Yoneyama S., Murase O., Miyajima K. Transbilayer transport of ions and lipids coupled with mastoparan X translocation. Biochemistry. 1996 Jun 25;35(25):8450–8456. doi: 10.1021/bi960342a. [DOI] [PubMed] [Google Scholar]
  30. Schwarz G., Arbuzova A. Pore kinetics reflected in the dequenching of a lipid vesicle entrapped fluorescent dye. Biochim Biophys Acta. 1995 Oct 4;1239(1):51–57. doi: 10.1016/0005-2736(95)00134-o. [DOI] [PubMed] [Google Scholar]
  31. Schwarz G., Robert C. H. Pore formation kinetics in membranes, determined from the release of marker molecules out of liposomes or cells. Biophys J. 1990 Sep;58(3):577–583. doi: 10.1016/S0006-3495(90)82401-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Wieprecht T., Dathe M., Beyermann M., Krause E., Maloy W. L., MacDonald D. L., Bienert M. Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes. Biochemistry. 1997 May 20;36(20):6124–6132. doi: 10.1021/bi9619987. [DOI] [PubMed] [Google Scholar]
  33. Wieprecht T., Dathe M., Epand R. M., Beyermann M., Krause E., Maloy W. L., MacDonald D. L., Bienert M. Influence of the angle subtended by the positively charged helix face on the membrane activity of amphipathic, antibacterial peptides. Biochemistry. 1997 Oct 21;36(42):12869–12880. doi: 10.1021/bi971398n. [DOI] [PubMed] [Google Scholar]
  34. Wieprecht T., Dathe M., Krause E., Beyermann M., Maloy W. L., MacDonald D. L., Bienert M. Modulation of membrane activity of amphipathic, antibacterial peptides by slight modifications of the hydrophobic moment. FEBS Lett. 1997 Nov 3;417(1):135–140. doi: 10.1016/s0014-5793(97)01266-0. [DOI] [PubMed] [Google Scholar]
  35. Wimley W. C., Selsted M. E., White S. H. Interactions between human defensins and lipid bilayers: evidence for formation of multimeric pores. Protein Sci. 1994 Sep;3(9):1362–1373. doi: 10.1002/pro.5560030902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Zasloff M. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5449–5453. doi: 10.1073/pnas.84.15.5449. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biophysical Journal are provided here courtesy of The Biophysical Society

RESOURCES